The instruction for medical use
of Hondroksid Torgovoye medicine a name
Mezhdunarodnoye the unlicensed name
Is not present
the Dosage form
Gel for external use of 5%
of 1 g of gel
sodium sulfate (in terms of 100% dry matter) 0.05 g,
excipients a dimethyl sulfoxide, propylene glycol, isopropanol, ethanol, sodium disulphite, methylparahydroxybenzoate, propilparagidroksibenzoat, carbomer, fragrance orange, the water purified contains active agent of chondroitin.
Yellowish translucent uniform gel with a fruit smell
Other drugs for topical treatment of diseases of the musculoskeletal system
the ATX M02AX Code
Hondroksid, gel is well soaked up. The dimethyl sulfoxide promotes the best penetration of chondroitin of sulfate through cellular membranes deep into of fabrics. Chondroitin sulfate after putting drug on skin quickly and selectively comes to a joint with achievement of the maximum concentration in 30 minutes and the subsequent two-phase removal of drug from cartilaginous tissue. End of a fast phase of removal happens in 1 hour after use. Time of deduction of drug in a joint is 5 hours.
Hondroksid, gel possesses the combined action slows down progressing of an osteoarthrosis and osteochondrosis, has anesthetic, anti-inflammatory effect, stimulates recovery of an articulate cartilage, improves mobility and reduces a swelling of joints.
Thanks to an optimum combination of components of gel mutual strengthening of their anesthetic and anti-inflammatory effects is noted. Drug use Hondroksid, gel allows to lower a dose of non-steroidal anti-inflammatory drugs.
Hondroksid, gel contains a natural component of chondroitin sulfate (high-molecular mucopolysaccharide) which takes part in creation of cartilaginous tissue. Chondroitin sulfate improves phosphorus-calcium exchange in cartilaginous tissue, reduces activity of the enzymes destroying cartilaginous tissue, slows down processes of a degeneration (destruction) of cartilaginous tissue, stimulates synthesis of glucosaminoglycans, interferes with collapse of connective tissue. It leads to reduction of morbidity and increase in mobility of the affected joints.
– degenerative dystrophic diseases of peripheral joints and a backbone (osteoarthrosis, including an osteoarthrosis of a temporal and mandibular joint, a spondylarthrosis, osteochondrosis, osteoporosis, heyropatiya).
Route of administration and doses
Outwardly. Hondroksid, gel is applied by 2-3 times a day to skin over the center of defeat and easily rub the patting movements within 2-3 minutes before full absorption. A course of treatment – from 2-3 weeks to 2-3 months. If necessary the course of treatment is repeated.
– allergic reactions
of the Contraindication
– hypersensitivity to drug components
– damage of integuments in the field of drawing
It is necessary to avoid hit of drug on mucous membranes and open wounds.
At hit on skin or clothes gel easily washes off, without leaving marks.
the Efficiency and safety of use of Hondroksid at children’s age are not established.
Pregnancy and a lactation
Efficiency and safety of use of Hondroksid during pregnancy and a lactation are not established.
The feature of influence of medicine on ability to drive the car or potentially dangerous mechanisms
does not influence ability to run the vehicle or potentially dangerous mechanisms.
About drug overdose cases Hondroksid, gel it was not reported.
A form of release and packing
On 30 g in tubas aluminum or polyethylene laminatny.
Each tuba together with the instruction for medical use in the state and Russian languages is placed in a pack from cardboard.
To Store storage conditions at
a temperature not higher than 25 S. Hranit out of children’s reach!
not to apply a period of storage after an expiration date.
JSC Nizhpharm Producer,
Russian Federation 603950, Nizhny Novgorod, GSP-459, Salganskaya St., 7
ph.: (831) 278-80-88
fax: (831) 430-72-28
a web the website: http://www.nizhpharm.ru
the Name and the country of the owner of the registration certificate
of JSC Nizhpharm, the Russian Federation
The address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods)
Representative office of JSC Nizhpharm
050043, Republic of Kazakhstan, Almaty, mdt. Khan-Taniri, 55b
ph.: (727) 398-64-91, 398-64-92, 398-64-93, 243-45-03, 243-45-04
fax: (727) 398-64-95